Literature DB >> 21668334

Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts.

Louis Monnier1, Claude Colette, David Owens.   

Abstract

The independent contribution of postprandial glucose (PPG) excursions to the overall glucose exposure and its role in the development of both micro- and macrovascular complications of diabetes remain subject to continuing debate in type 2 diabetes. Discussion continues on whether postprandial hyperglycemia is the main contributor to the overall hyperglycemia in fairly well-controlled individuals, whereas basal hyperglycemia becomes the preponderant contributor in poorly controlled patients. The concern about the role of PPG as a risk factor for diabetes complications is related to the controversial data obtained in individuals with impaired glucose tolerance. It remains, however, that the total glucose exposure as reflected by hemoglobin A1c (HbA1c) levels is an undoubted major vascular risk factor. Excluding the contribution of PPG is nonsensical. In support of this position is the fact that the absolute impact of PPG on HbA1c, expressed as percentage levels of HbA1c, remains constant at 1% across the HbA1c continuum in non-insulin-treated type 2 diabetes patients. This key feature clearly depicts the absolute contribution of PPG in contrast to its relative contribution and better explains why PPG contributes to the excess of glycation with the basal hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668334     DOI: 10.1089/dia.2010.0239

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  24 in total

Review 1.  Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.

Authors:  L Monnier; C Colette; S Dejager; D R Owens
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

Review 2.  A Plethora of GLP-1 Agonists: Decisions About What to Use and When.

Authors:  Susan L Samson; Alan J Garber
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

3.  Blood glucose self-monitoring patterns in Mexican Americans: further lessons from the Starr County Border Health Initiative.

Authors:  Heather E Cuevas; Sharon A Brown; Alexandra A García; Mary Winter; Adama Brown; Craig L Hanis
Journal:  Diabetes Technol Ther       Date:  2014-10-07       Impact factor: 6.118

4.  High fat diet attenuates glucose-dependent facilitation of 5-HT3 -mediated responses in rat gastric vagal afferents.

Authors:  Amanda E Troy; Sarah S Simmonds; Sean D Stocker; Kirsteen N Browning
Journal:  J Physiol       Date:  2015-11-15       Impact factor: 5.182

Review 5.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

Review 6.  Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.

Authors:  D R Owens
Journal:  Diabet Med       Date:  2013-03       Impact factor: 4.359

7.  Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.

Authors:  Matthew Riddle; Guillermo Umpierrez; Andres DiGenio; Rong Zhou; Julio Rosenstock
Journal:  Diabetes Care       Date:  2011-10-25       Impact factor: 19.112

8.  Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches.

Authors:  J B Møller; N R Kristensen; S Klim; M O Karlsson; S H Ingwersen; M C Kjellsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-07-02

9.  Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.

Authors:  Elsemiek E C Engwerda; Cees J Tack; Bastiaan E de Galan
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

Review 10.  Lixisenatide as add-on therapy to basal insulin.

Authors:  Dominique Xavier Brown; Emma Louise Butler; Marc Evans
Journal:  Drug Des Devel Ther       Date:  2013-12-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.